According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Acute Myeloid Leukemia Biomarker Detection Market

Acute myeloid leukemia is a malignant neoplastic disease that usually results from the deterioration of stem cells in the bone marrow. Biomarker detection is a method that can detect specific molecular or genetic variations of leukemia cells, which can be used to diagnose AML, evaluate patient prognosis, and guide the selection of treatment options.

The global Acute Myeloid Leukemia Biomarker Detection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Acute Myeloid Leukemia Biomarker Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Myeloid Leukemia Biomarker Detection.

Report Scope

The Acute Myeloid Leukemia Biomarker Detection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Acute Myeloid Leukemia Biomarker Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acute Myeloid Leukemia Biomarker Detection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Acute Myeloid Leukemia Biomarker Detection Market Report

Report Metric	Details
Report Name	Acute Myeloid Leukemia Biomarker Detection Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Next Generation Sequencing Technology PCR Detection Technology
Segment by Application	Hospital Research Institutions Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott Laboratories, Bio-Rad Laboratories, Inc., Genmark Saghlk Orinleri, Laboratory Corporation of America Holdings, Danaher, Medaysis Company, NeoGenomics Laboratories, QIAGEN N.V., Thermo Fisher Scientific, Inc., GeneTex
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Acute Myeloid Leukemia Biomarker Detection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Acute Myeloid Leukemia Biomarker Detection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Acute Myeloid Leukemia Biomarker Detection Market report?

Ans: The main players in the Acute Myeloid Leukemia Biomarker Detection Market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Genmark Saghlk Orinleri, Laboratory Corporation of America Holdings, Danaher, Medaysis Company, NeoGenomics Laboratories, QIAGEN N.V., Thermo Fisher Scientific, Inc., GeneTex

What are the Application segmentation covered in the Acute Myeloid Leukemia Biomarker Detection Market report?

Ans: The Applications covered in the Acute Myeloid Leukemia Biomarker Detection Market report are Hospital, Research Institutions, Other

What are the Type segmentation covered in the Acute Myeloid Leukemia Biomarker Detection Market report?

Ans: The Types covered in the Acute Myeloid Leukemia Biomarker Detection Market report are Next Generation Sequencing Technology, PCR Detection Technology

1 Acute Myeloid Leukemia Biomarker Detection Market Overview

1.1 Product Overview and Scope of Acute Myeloid Leukemia Biomarker Detection

1.2 Acute Myeloid Leukemia Biomarker Detection Segment by Type

1.2.1 Global Acute Myeloid Leukemia Biomarker Detection Market Value Comparison by Type (2024-2030)

1.2.2 Next Generation Sequencing Technology

1.2.3 PCR Detection Technology

1.3 Acute Myeloid Leukemia Biomarker Detection Segment by Application

1.3.1 Global Acute Myeloid Leukemia Biomarker Detection Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Research Institutions

1.3.4 Other

1.4 Global Acute Myeloid Leukemia Biomarker Detection Market Size Estimates and Forecasts

1.4.1 Global Acute Myeloid Leukemia Biomarker Detection Revenue 2019-2030

1.4.2 Global Acute Myeloid Leukemia Biomarker Detection Sales 2019-2030

1.4.3 Global Acute Myeloid Leukemia Biomarker Detection Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Acute Myeloid Leukemia Biomarker Detection Market Competition by Manufacturers

2.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Manufacturers (2019-2024)

2.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Acute Myeloid Leukemia Biomarker Detection Average Price by Manufacturers (2019-2024)

2.4 Global Acute Myeloid Leukemia Biomarker Detection Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection, Product Type & Application

2.7 Acute Myeloid Leukemia Biomarker Detection Market Competitive Situation and Trends

2.7.1 Acute Myeloid Leukemia Biomarker Detection Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Acute Myeloid Leukemia Biomarker Detection Players Market Share by Revenue

2.7.3 Global Acute Myeloid Leukemia Biomarker Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Acute Myeloid Leukemia Biomarker Detection Retrospective Market Scenario by Region

3.1 Global Acute Myeloid Leukemia Biomarker Detection Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Acute Myeloid Leukemia Biomarker Detection Global Acute Myeloid Leukemia Biomarker Detection Sales by Region: 2019-2030

3.2.1 Global Acute Myeloid Leukemia Biomarker Detection Sales by Region: 2019-2024

3.2.2 Global Acute Myeloid Leukemia Biomarker Detection Sales by Region: 2025-2030

3.3 Global Acute Myeloid Leukemia Biomarker Detection Global Acute Myeloid Leukemia Biomarker Detection Revenue by Region: 2019-2030

3.3.1 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Region: 2019-2024

3.3.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Region: 2025-2030

3.4 North America Acute Myeloid Leukemia Biomarker Detection Market Facts & Figures by Country

3.4.1 North America Acute Myeloid Leukemia Biomarker Detection Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2019-2030)

3.4.3 North America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Acute Myeloid Leukemia Biomarker Detection Market Facts & Figures by Country

3.5.1 Europe Acute Myeloid Leukemia Biomarker Detection Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Acute Myeloid Leukemia Biomarker Detection Sales by Country (2019-2030)

3.5.3 Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Acute Myeloid Leukemia Biomarker Detection Market Facts & Figures by Country

3.6.1 Asia Pacific Acute Myeloid Leukemia Biomarker Detection Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Acute Myeloid Leukemia Biomarker Detection Sales by Country (2019-2030)

3.6.3 Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Acute Myeloid Leukemia Biomarker Detection Market Facts & Figures by Country

3.7.1 Latin America Acute Myeloid Leukemia Biomarker Detection Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2019-2030)

3.7.3 Latin America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Market Facts & Figures by Country

3.8.1 Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Sales by Country (2019-2030)

3.8.3 Middle East and Africa Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Acute Myeloid Leukemia Biomarker Detection Sales by Type (2019-2030)

4.1.1 Global Acute Myeloid Leukemia Biomarker Detection Sales by Type (2019-2024)

4.1.2 Global Acute Myeloid Leukemia Biomarker Detection Sales by Type (2025-2030)

4.1.3 Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2019-2030)

4.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Type (2019-2030)

4.2.1 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Type (2019-2024)

4.2.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Type (2025-2030)

4.2.3 Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Type (2019-2030)

4.3 Global Acute Myeloid Leukemia Biomarker Detection Price by Type (2019-2030)

5 Segment by Application

5.1 Global Acute Myeloid Leukemia Biomarker Detection Sales by Application (2019-2030)

5.1.1 Global Acute Myeloid Leukemia Biomarker Detection Sales by Application (2019-2024)

5.1.2 Global Acute Myeloid Leukemia Biomarker Detection Sales by Application (2025-2030)

5.1.3 Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2019-2030)

5.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Application (2019-2030)

5.2.1 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Application (2019-2024)

5.2.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Application (2025-2030)

5.2.3 Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Application (2019-2030)

5.3 Global Acute Myeloid Leukemia Biomarker Detection Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Abbott Laboratories

6.1.1 Abbott Laboratories Corporation Information

6.1.2 Abbott Laboratories Description and Business Overview

6.1.3 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolio

6.1.5 Abbott Laboratories Recent Developments/Updates

6.2 Bio-Rad Laboratories, Inc.

6.2.1 Bio-Rad Laboratories, Inc. Corporation Information

6.2.2 Bio-Rad Laboratories, Inc. Description and Business Overview

6.2.3 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolio

6.2.5 Bio-Rad Laboratories, Inc. Recent Developments/Updates

6.3 Genmark Saghlk Orinleri

6.3.1 Genmark Saghlk Orinleri Corporation Information

6.3.2 Genmark Saghlk Orinleri Description and Business Overview

6.3.3 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product Portfolio

6.3.5 Genmark Saghlk Orinleri Recent Developments/Updates

6.4 Laboratory Corporation of America Holdings

6.4.1 Laboratory Corporation of America Holdings Corporation Information

6.4.2 Laboratory Corporation of America Holdings Description and Business Overview

6.4.3 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product Portfolio

6.4.5 Laboratory Corporation of America Holdings Recent Developments/Updates

6.5 Danaher

6.5.1 Danaher Corporation Information

6.5.2 Danaher Description and Business Overview

6.5.3 Danaher Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Danaher Acute Myeloid Leukemia Biomarker Detection Product Portfolio

6.5.5 Danaher Recent Developments/Updates

6.6 Medaysis Company

6.6.1 Medaysis Company Corporation Information

6.6.2 Medaysis Company Description and Business Overview

6.6.3 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product Portfolio

6.6.5 Medaysis Company Recent Developments/Updates

6.7 NeoGenomics Laboratories

6.6.1 NeoGenomics Laboratories Corporation Information

6.6.2 NeoGenomics Laboratories Description and Business Overview

6.6.3 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolio

6.7.5 NeoGenomics Laboratories Recent Developments/Updates

6.8 QIAGEN N.V.

6.8.1 QIAGEN N.V. Corporation Information

6.8.2 QIAGEN N.V. Description and Business Overview

6.8.3 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2019-2024)

6.8.4 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product Portfolio

6.8.5 QIAGEN N.V. Recent Developments/Updates

6.9 Thermo Fisher Scientific, Inc.

6.9.1 Thermo Fisher Scientific, Inc. Corporation Information

6.9.2 Thermo Fisher Scientific, Inc. Description and Business Overview

6.9.3 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolio

6.9.5 Thermo Fisher Scientific, Inc. Recent Developments/Updates

6.10 GeneTex

6.10.1 GeneTex Corporation Information

6.10.2 GeneTex Description and Business Overview

6.10.3 GeneTex Acute Myeloid Leukemia Biomarker Detection Sales, Revenue and Gross Margin (2019-2024)

6.10.4 GeneTex Acute Myeloid Leukemia Biomarker Detection Product Portfolio

6.10.5 GeneTex Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Acute Myeloid Leukemia Biomarker Detection Industry Chain Analysis

7.2 Acute Myeloid Leukemia Biomarker Detection Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Acute Myeloid Leukemia Biomarker Detection Production Mode & Process

7.4 Acute Myeloid Leukemia Biomarker Detection Sales and Marketing

7.4.1 Acute Myeloid Leukemia Biomarker Detection Sales Channels

7.4.2 Acute Myeloid Leukemia Biomarker Detection Distributors

7.5 Acute Myeloid Leukemia Biomarker Detection Customers

8 Acute Myeloid Leukemia Biomarker Detection Market Dynamics

8.1 Acute Myeloid Leukemia Biomarker Detection Industry Trends

8.2 Acute Myeloid Leukemia Biomarker Detection Market Drivers

8.3 Acute Myeloid Leukemia Biomarker Detection Market Challenges

8.4 Acute Myeloid Leukemia Biomarker Detection Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Abbott Laboratories

Bio-Rad Laboratories Inc

Laboratory Corporation of America Holdings

Danaher

Neogenomics Laboratories

QIAGEN N V

Thermo Fisher Scientific Inc

GeneTex

Genmark Saghlk Orinleri

Medaysis Company

List of Tables

Table 1. Global Acute Myeloid Leukemia Biomarker Detection Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Acute Myeloid Leukemia Biomarker Detection Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Acute Myeloid Leukemia Biomarker Detection Market Competitive Situation by Manufacturers in 2023

Table 4. Global Acute Myeloid Leukemia Biomarker Detection Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Acute Myeloid Leukemia Biomarker Detection Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Acute Myeloid Leukemia Biomarker Detection Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Acute Myeloid Leukemia Biomarker Detection Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Acute Myeloid Leukemia Biomarker Detection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection, Product Type & Application

Table 12. Global Key Manufacturers of Acute Myeloid Leukemia Biomarker Detection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Acute Myeloid Leukemia Biomarker Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia Biomarker Detection as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Acute Myeloid Leukemia Biomarker Detection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Acute Myeloid Leukemia Biomarker Detection Sales by Region (2019-2024) & (K Units)

Table 18. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Region (2019-2024)

Table 19. Global Acute Myeloid Leukemia Biomarker Detection Sales by Region (2025-2030) & (K Units)

Table 20. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Region (2025-2030)

Table 21. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Region (2019-2024)

Table 23. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Region (2025-2030)

Table 25. North America Acute Myeloid Leukemia Biomarker Detection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2019-2024) & (K Units)

Table 27. North America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2025-2030) & (K Units)

Table 28. North America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Acute Myeloid Leukemia Biomarker Detection Sales by Country (2019-2024) & (K Units)

Table 32. Europe Acute Myeloid Leukemia Biomarker Detection Sales by Country (2025-2030) & (K Units)

Table 33. Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Acute Myeloid Leukemia Biomarker Detection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Acute Myeloid Leukemia Biomarker Detection Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Acute Myeloid Leukemia Biomarker Detection Sales (K Units) by Type (2019-2024)

Table 51. Global Acute Myeloid Leukemia Biomarker Detection Sales (K Units) by Type (2025-2030)

Table 52. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2019-2024)

Table 53. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2025-2030)

Table 54. Global Acute Myeloid Leukemia Biomarker Detection Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Acute Myeloid Leukemia Biomarker Detection Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Type (2019-2024)

Table 57. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Type (2025-2030)

Table 58. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Type (2019-2024)

Table 59. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Type (2025-2030)

Table 60. Global Acute Myeloid Leukemia Biomarker Detection Sales (K Units) by Application (2019-2024)

Table 61. Global Acute Myeloid Leukemia Biomarker Detection Sales (K Units) by Application (2025-2030)

Table 62. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2019-2024)

Table 63. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2025-2030)

Table 64. Global Acute Myeloid Leukemia Biomarker Detection Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Acute Myeloid Leukemia Biomarker Detection Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Application (2019-2024)

Table 67. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Application (2025-2030)

Table 68. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Application (2019-2024)

Table 69. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Application (2025-2030)

Table 70. Abbott Laboratories Corporation Information

Table 71. Abbott Laboratories Description and Business Overview

Table 72. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product

Table 74. Abbott Laboratories Recent Developments/Updates

Table 75. Bio-Rad Laboratories, Inc. Corporation Information

Table 76. Bio-Rad Laboratories, Inc. Description and Business Overview

Table 77. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product

Table 79. Bio-Rad Laboratories, Inc. Recent Developments/Updates

Table 80. Genmark Saghlk Orinleri Corporation Information

Table 81. Genmark Saghlk Orinleri Description and Business Overview

Table 82. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product

Table 84. Genmark Saghlk Orinleri Recent Developments/Updates

Table 85. Laboratory Corporation of America Holdings Corporation Information

Table 86. Laboratory Corporation of America Holdings Description and Business Overview

Table 87. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product

Table 89. Laboratory Corporation of America Holdings Recent Developments/Updates

Table 90. Danaher Corporation Information

Table 91. Danaher Description and Business Overview

Table 92. Danaher Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Danaher Acute Myeloid Leukemia Biomarker Detection Product

Table 94. Danaher Recent Developments/Updates

Table 95. Medaysis Company Corporation Information

Table 96. Medaysis Company Description and Business Overview

Table 97. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product

Table 99. Medaysis Company Recent Developments/Updates

Table 100. NeoGenomics Laboratories Corporation Information

Table 101. NeoGenomics Laboratories Description and Business Overview

Table 102. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product

Table 104. NeoGenomics Laboratories Recent Developments/Updates

Table 105. QIAGEN N.V. Corporation Information

Table 106. QIAGEN N.V. Description and Business Overview

Table 107. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product

Table 109. QIAGEN N.V. Recent Developments/Updates

Table 110. Thermo Fisher Scientific, Inc. Corporation Information

Table 111. Thermo Fisher Scientific, Inc. Description and Business Overview

Table 112. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product

Table 114. Thermo Fisher Scientific, Inc. Recent Developments/Updates

Table 115. GeneTex Corporation Information

Table 116. GeneTex Description and Business Overview

Table 117. GeneTex Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. GeneTex Acute Myeloid Leukemia Biomarker Detection Product

Table 119. GeneTex Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Acute Myeloid Leukemia Biomarker Detection Distributors List

Table 123. Acute Myeloid Leukemia Biomarker Detection Customers List

Table 124. Acute Myeloid Leukemia Biomarker Detection Market Trends

Table 125. Acute Myeloid Leukemia Biomarker Detection Market Drivers

Table 126. Acute Myeloid Leukemia Biomarker Detection Market Challenges

Table 127. Acute Myeloid Leukemia Biomarker Detection Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Acute Myeloid Leukemia Biomarker Detection

Figure 2. Global Acute Myeloid Leukemia Biomarker Detection Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Acute Myeloid Leukemia Biomarker Detection Market Share by Type in 2023 & 2030

Figure 4. Next Generation Sequencing Technology Product Picture

Figure 5. PCR Detection Technology Product Picture

Figure 6. Global Acute Myeloid Leukemia Biomarker Detection Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Acute Myeloid Leukemia Biomarker Detection Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Research Institutions

Figure 10. Other

Figure 11. Global Acute Myeloid Leukemia Biomarker Detection Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Acute Myeloid Leukemia Biomarker Detection Market Size (2019-2030) & (US$ Million)

Figure 13. Global Acute Myeloid Leukemia Biomarker Detection Sales (2019-2030) & (K Units)

Figure 14. Global Acute Myeloid Leukemia Biomarker Detection Average Price (US$/Unit) & (2019-2030)

Figure 15. Acute Myeloid Leukemia Biomarker Detection Report Years Considered

Figure 16. Acute Myeloid Leukemia Biomarker Detection Sales Share by Manufacturers in 2023

Figure 17. Global Acute Myeloid Leukemia Biomarker Detection Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Acute Myeloid Leukemia Biomarker Detection Players: Market Share by Revenue in 2023

Figure 19. Acute Myeloid Leukemia Biomarker Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Acute Myeloid Leukemia Biomarker Detection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2019-2030)

Figure 22. North America Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2019-2030)

Figure 23. United States Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2019-2030)

Figure 26. Europe Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2019-2030)

Figure 27. Germany Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Region (2019-2030)

Figure 34. China Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2019-2030)

Figure 42. Latin America Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2019-2030)

Figure 43. Mexico Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Acute Myeloid Leukemia Biomarker Detection by Type (2019-2030)

Figure 52. Global Revenue Market Share of Acute Myeloid Leukemia Biomarker Detection by Type (2019-2030)

Figure 53. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Acute Myeloid Leukemia Biomarker Detection by Application (2019-2030)

Figure 55. Global Revenue Market Share of Acute Myeloid Leukemia Biomarker Detection by Application (2019-2030)

Figure 56. Global Acute Myeloid Leukemia Biomarker Detection Price (US$/Unit) by Application (2019-2030)

Figure 57. Acute Myeloid Leukemia Biomarker Detection Value Chain

Figure 58. Acute Myeloid Leukemia Biomarker Detection Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26D6003

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Chemotherapy Chairs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-26D13514

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Drugs for Non-Small Cell Lung Cancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-33S12067

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Oncological Phototherapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-11U13658

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Acute Myeloid Leukemia Biomarker Detection Market Research Report 2024

Published Date: July 2024

Report Code: QYRE-Auto-0Z14347

Global Acute Myeloid Leukemia Biomarker Detection Market Research Report 2024

FEATURED COMPANIES

Acute Myeloid Leukemia Biomarker Detection Market Size

Acute Myeloid Leukemia Biomarker Detection Market

Report Scope

Scope of Acute Myeloid Leukemia Biomarker Detection Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Acute Myeloid Leukemia Biomarker Detection Market report?

What are the Application segmentation covered in the Acute Myeloid Leukemia Biomarker Detection Market report?

What are the Type segmentation covered in the Acute Myeloid Leukemia Biomarker Detection Market report?

FEATURED COMPANIES

RELATED REPORTS